Pamukcu R - Search Results

1

Effects of sulindac and its metabolites on growth and apoptosis in human mammary epithelial and breast carcinoma cell lines.

Han EK, Arber N, Yamamoto H, Lim JT, Delohery T, Pamukcu R, Piazza GA, Xing WQ, Weinstein IB. Han EK, et al. Among authors: pamukcu r. Breast Cancer Res Treat. 1998 Apr;48(3):195-203. doi: 10.1023/a:1005924730450. Breast Cancer Res Treat. 1998. PMID: 9598866

2

Exisulind and related compounds inhibit expression and function of the androgen receptor in human prostate cancer cells.

Lim JT, Piazza GA, Pamukcu R, Thompson WJ, Weinstein IB. Lim JT, et al. Among authors: pamukcu r. Clin Cancer Res. 2003 Oct 15;9(13):4972-82. Clin Cancer Res. 2003. PMID: 14581372

3

Sulfone metabolite of sulindac inhibits mammary carcinogenesis.

Thompson HJ, Jiang C, Lu J, Mehta RG, Piazza GA, Paranka NS, Pamukcu R, Ahnen DJ. Thompson HJ, et al. Among authors: pamukcu r. Cancer Res. 1997 Jan 15;57(2):267-71. Cancer Res. 1997. PMID: 9000566

4

A K-ras oncogene increases resistance to sulindac-induced apoptosis in rat enterocytes.

Arber N, Han EK, Sgambato A, Piazza GA, Delohery TM, Begemann M, Weghorst CM, Kim NH, Pamukcu R, Ahnen DJ, Reed JC, Weinstein IB, Holt PR. Arber N, et al. Among authors: pamukcu r. Gastroenterology. 1997 Dec;113(6):1892-900. doi: 10.1016/s0016-5085(97)70008-8. Gastroenterology. 1997. PMID: 9394728

5

Exisulind (sulindac sulfone) suppresses growth of human prostate cancer in a nude mouse xenograft model by increasing apoptosis.

Goluboff ET, Shabsigh A, Saidi JA, Weinstein IB, Mitra N, Heitjan D, Piazza GA, Pamukcu R, Buttyan R, Olsson CA. Goluboff ET, et al. Among authors: pamukcu r. Urology. 1999 Feb;53(2):440-5. doi: 10.1016/s0090-4295(98)00513-5. Urology. 1999. PMID: 9933075 Free article.

6

Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines.

Lim JT, Piazza GA, Han EK, Delohery TM, Li H, Finn TS, Buttyan R, Yamamoto H, Sperl GJ, Brendel K, Gross PH, Pamukcu R, Weinstein IB. Lim JT, et al. Among authors: pamukcu r. Biochem Pharmacol. 1999 Oct 1;58(7):1097-107. doi: 10.1016/s0006-2952(99)00200-2. Biochem Pharmacol. 1999. PMID: 10484067 Free article.

7

Cyclic GMP mediates apoptosis induced by sulindac derivatives via activation of c-Jun NH2-terminal kinase 1.

Soh JW, Mao Y, Kim MG, Pamukcu R, Li H, Piazza GA, Thompson WJ, Weinstein IB. Soh JW, et al. Among authors: pamukcu r. Clin Cancer Res. 2000 Oct;6(10):4136-41. Clin Cancer Res. 2000. PMID: 11051267

8

CP248, a derivative of exisulind, causes growth inhibition, mitotic arrest, and abnormalities in microtubule polymerization in glioma cells.

Yoon JT, Palazzo AF, Xiao D, Delohery TM, Warburton PE, Bruce JN, Thompson WJ, Sperl G, Whitehead C, Fetter J, Pamukcu R, Gundersen GG, Weinstein IB. Yoon JT, et al. Among authors: pamukcu r. Mol Cancer Ther. 2002 Apr;1(6):393-404. Mol Cancer Ther. 2002. PMID: 12477052

9

Vasodilator-stimulated phosphoprotein (VASP) phosphorylation provides a biomarker for the action of exisulind and related agents that activate protein kinase G.

Deguchi A, Soh JW, Li H, Pamukcu R, Thompson WJ, Weinstein IB. Deguchi A, et al. Among authors: pamukcu r. Mol Cancer Ther. 2002 Aug;1(10):803-9. Mol Cancer Ther. 2002. PMID: 12492113

10

Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis.

Piazza GA, Rahm AL, Krutzsch M, Sperl G, Paranka NS, Gross PH, Brendel K, Burt RW, Alberts DS, Pamukcu R, et al. Piazza GA, et al. Among authors: pamukcu r. Cancer Res. 1995 Jul 15;55(14):3110-6. Cancer Res. 1995. PMID: 7606732

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters